In summary, our results showed that SE1 reduces the metastatic ability of tumor cells by blocking expression and activities of MMP-9 and this was related to the downregulation of the NF-κB and p38 and JNK signaling pathways. This evidence concerns the gene NFKB1 and neoplasm.